Treatments & Interventions
Fluoxetine hydrochloride
substance
Quetiapine fumarate
substance
Fluoxetine
substance
Quetiapine
substance
Escitalopram
substance
Duloxetine
substance
Escitalopram oxalate
substance
Duloxetine hydrochloride
substance
Desvenlafaxine
substance
Desvenlafaxine succinate
substance
Milnacipran
substance
Milnacipran hydrochloride
substance
Vilazodone
substance
Vilazodone hydrochloride
substance
Lurasidone
substance
Lurasidone hydrochloride
substance
Vortioxetine
substance
Vortioxetine hydrobromide
substance
Brexpiprazole
substance
Levomilnacipran hydrochloride
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 370143000
- UMLS CUI
- C1269683
- Fully Specified Name
- Major depressive disorder (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 1
- Known Treatments
- 20
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.